Concise review: Role and function of the ubiquitin-proteasome system in mammalian stem and progenitor cells

Stem Cells

Volumn 25, Issue 10, 2007, Pages 2408-2418

  Naujokat, Cord ^a   Šarić, Tomo ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Embryonic stem cells; Hematopoietic stem cells; Mesenchymal stem cells; Neural stem cells; Proteasome; Ubiquitin

Indexed keywords

PROTEASOME; UBIQUITIN;

CELL DIFFERENTIATION; CELL HOMING; CELL MIGRATION; CELL SURVIVAL; EMBRYONIC STEM CELL; HUMAN; MAMMAL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEOMICS; REVIEW;

ANIMALS; BRAIN; EMBRYONIC STEM CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAMMALS; MESENCHYMAL STEM CELLS; MICE; NEURONS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; STEM CELL TRANSPLANTATION; STEM CELLS; UBIQUITIN;

EUKARYOTA; MAMMALIA;

EID: 35348886029     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0255     Document Type: Review

References (218)

1. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998;67:425-479.
2. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction. Physiol Rev 2002;82:373-428.
3. Ciechanover A. The ubiquitin proteolytic system. Neurology 2006;66:S7-S19.
4. Baumeister W, Walz J, Zühl F et al. The proteasome: Paradigm of a self-compartmentalizing protease. Cell 1998;92:367-380.
5. Voges D, Zwickl P, Baumeister W. The 26S proteasome: A molecular machine designed for controlled proteolysis. Annu Rev Biochem 1999;68:1015-1068.
6. Naujokat C, Hoffmann S. Role and function of the 26S proteasome in proliferation and apoptosis. Lab Invest 2002;82:965-980.
7. Rock KL, York IA, Saric T et al. Protein degradation and the generation of MHC class I-presented peptides. Adv Immunol 2002;80:1-70.
8. Krüger E, Kuckelkorn U, Sijts A et al. The components of the proteasome and their role in MHC class I antigen processing. Rev Physiol Biochem Pharmacol 2003;148:81-104.
9. Wolf DH, Hilt W. The proteasome: A proteolytic nanomachine of cell regulation and waste disposal. Biochim Biophys Acta 2004;1695:19-31.
10. Goldberg AL. Protein degradation and protection against misfolded and damaged proteins. Nature 2003;426:895-899.
11. Pickart CM, Eddins MJ. Ubiquitin: Structures, functions, mechanisms. Biochim Biophys Acta 2004;1695:55-72.
12. Groll M, Ditzel L, Löwe J et al. Structure of 20S proteasome from yeast at 2.4 Å resolution. Nature 1997;386:463-471.
13. Glickman MH, Rubin DM, Coux O et al. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and elF3. Cell 1998;94:615-623.
14. Hochstrasser M. Evolution and function of ubiquitin-like protein-conjugation systems. Nat Cell Biol 2000;2:E153-E157.
15. Rechsteiner MC. Ubiquitin-mediated proteolysis: An ideal pathway for systems biology analysis. Adv Exp Med Biol 2004;547:49-59.
16. DeRenzo C, Seydoux G. A clean start: Degradation of maternal proteins at the oocyt-to-embryo transition. Trends Cell Biol 2004;14:420-426.
17. Bowerman B, Kurz T. Degrade to create: Developmental requirements for ubiquitin-mediated proteolysis during early C. elegans embryogenesis. Development 2006;133:773-784.
18. Ciechanover A. The ubiquitin proteolytic system and pathogenesis of human diseases: A novel platform for mechanism-based drug targeting. Biochem Soc Trans 2003;31:474-481.
19. Golab J, Bauer TM, Daniel V et al. Role of the ubiquitin-proteasome pathway in the diagnosis of human diseases. Clin Chim Acta 2004;340:27-40.
20. Adams J, Palombella VJ, Sausville EA et al. Proteasome inhibitors: A novel class of potent and effective antitumor agents. Cancer Res 1999;59:2615-2622.
21. Blanco B, Perez-Simon JA, Sanchez-Abarca LI et al. Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of TH1 cytokines. Blood 2006;107:3575-3583.
22. Naujokat C, Berges C, Höh A et al. Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells. Immunology 2007;120:120-132.
23. Voorhees PM, Orlowski RZ. The proteasome and proteasome inhibitors in cancer therapy. Annu Rev Pharmacol Toxicol 2006;46:189-213.
24. Mattingly LH, Gault RA, Murphy WJ. Use of systemic proteasome inhibition as an immune-modulating agent in disease. Endocr Metab Immune Disord Drug Targets 2007;7:29-34.
25. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981;292:154-156.
26. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981;78:7634-7638.
27. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
28. Andrews PW. Teratocarcinomas and human embryology: Pluripotent human EC cell lines. APMIS 1998;106:158-167.
29. Czyz J, Wiese C, Rolletschek A et al. Potential of embryonic and adult stem cells in vitro. Biol Chem 2003;384:1391-1409.
30. Xu HM, Liao B, Zhang QJ et al. Wwp2, an E3 ubiquitin ligase that targets transcription factor Oct-4 for ubiquitination. J Biol Chem 2004;279:23495-23503.
31. Park SW, Hu X, Gupta P et al. SUMOylation of Tr2 orphan receptor involves Pml and fine-tunes Oct4 expression in stem cells. Nat Struct Mol Biol 2007;14:68-75.
32. Babaie Y, Herwig R, Greber B et al. Analysis of oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. STEM CELLS 2007;25:500-510.
33. Baharvand H, Hajheidari M, Ashtiani SK et al. Proteomic signature of human embryonic stem cells. Proteomics 2006;6:3544-3549.
34. Hernebring M, Brolen G, Aguilaniu H et al. Elimination of damaged proteins during differentiation of embryonic stem cells. Proc Natl Acad Sci U S A 2006;103:7700-7705.
35. Muratani M, Tansey WP. How the ubiquitin-proteasome system controls transcription. Nat Rev Mol Cell Biol 2003;4:192-201.
36. Azuara V, Perry P, Sauer S et al. Chromatin signatures of pluripotent cell lines. Nat Cell Biol 2006;8:532-538.
37. Bernstein BE, Mikkelsen TS, Xie X et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006;125:315-326.
38. Szutorisz H, Georgiou A, Tora L et al. The proteasome restricts permissive transcription at tissue-specific gene loci in embryonic stem cells. Cell 2006;127:1375-1388.
39. Boyer LA, Plath K, Zeitlinger J et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006;441:349-353.
40. Lee TI, Jenner RG, Boyer LA et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006;125:301-313.
41. Wang H, Wang L, Erdjument-Bromage H et al. Role of histone H2A ubiquitination in Polycomb silencing. Nature 2004;431:873-878.
42. de Napoles M, Mermoud JE, Wakao R et al. Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation. Dev Cell 2004;7:663-676.
43. Cao R, Tsukada Y, Zhang Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing. Mol Cell 2005;20:845-854.
44. Valk-Lingbeek ME, Bruggeman SW, van Lohuizen M. Stem cells and cancer; the polycomb connection. Cell 2004;118:409-418.
45. Akala OO, Clarke MF. Hematopoietic stem cell self-renewal. Curr Opin Genet Dev 2006;16:496-501.
46. Ben-Saadon R, Zaaroor D, Ziv T et al. The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity. Mol Cell 2006;24:701-711.
47. Jian R, Cheng X, Jiang J et al. A cDNA-based random RNAi library for functional genetic screens in embryonic stem cells. STEM CELLS 2007;25:1904-1912.
48. Williams RL, Hilton DJ, Pease S et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 1988;336:684-687.
49. Xiao L, Yuan X, Sharkis SJ. Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. STEM CELLS 2006;24:1476-1486.
50. Dravid G, Ye Z, Hammond H et al. Defining the role of Wnt/betacatenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells. STEM CELLS 2005;23:1489-1501.
51. Levenstein ME, Ludwig TE, Xu RH et al. Basic fibroblast growth factor support of human embryonic stem cell self-renewal. STEM CELLS 2006;24:568-574.
52. Daino H, Matsumura I, Takada K et al. Induction of apoptosis by extracellular ubiquitin in human hematopoietic cells: Possible involvement of STAT3 degradation by proteasome pathway in interleukin 6-dependent hematopoietic cells. Blood 2000;95:2577-2585.
53. Perry E, Tsruya R, Levitsky P et al. TMF/ARA160 is a BC-boxcontaining protein that mediates the degradation of Stat3. Oncogene 2004;23:8908-8919.
54. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004;20:781-810.
55. Lai EC. Protein degradation: Four E3s for the notch pathway. Curr Biol 2002;12:R74-R78.
56. Wang T. The 26S proteasome system in the signaling pathways of TGF-beta superfamily. Front Biosci 2003;8:d1109-d1127.
57. Mavrakis KJ, Andrew RL, Lee KL et al. Arkadia enhances nodal/TGF-beta signaling by coupling phospho-smad2/3 activity and turnover. PLoS Biol 2007;5:e67.
58. Hann SR. Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function. Semin Cancer Biol 2006;16:288-302.
59. Barker N, Morin PJ, Clevers H. The Yin-Yang of TCF/beta-catenin signaling. Adv Cancer Res 2000;77:1-24.
60. Johansson CB, Momma S, Clarke DL et al. Identification of a neural stem cell in the adult mammalian central nervous system. Cell 1999;96:25-34.
61. Doetsch F, Caillé I, Lim DA et al. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999;97:703-716.
62. Chiasson BJ, Tropepe V, Morshead CM et al. Adult mammalian forebrain ependymal and subependymal cells demonstrate proliferative potential, but only subependymal cells have neural stem cell characteristics. J Neurosci 1999;19:4462-4471.
63. Sanai N, Tramontin AD, Quinones-Hinojosa A et al. Unique astrocyte ribbon in adult human brain contains neural stem cells but lack chain migration. Nature 2004;427:740-744.
64. Gage FH. Mammalian neural stem cells. Science 2000;287:1433-1438.
65. Galli R, Gritti A, Bonfanti L et al. Neural stem cells. Circ Res 2003;92:598-608.
66. Alvarez-Buylla A, Lim DA. For the long run: Maintaining germinal niches in the adult brain. Neuron 2004;41:683-686.
67. Quinones-Hinojosa A, Sanai N, Soriano-Navarro M et al. Cellular composition of the adult human subventricular zone: A niche of neural stem cells. J Comp Neurol 2006;494:415-434.
68. Palmer TD, Takahashi H, Gage FH. The adult rat hippocampus contains primordial neural stem cells. Mol Cell Neurosci 1997;8:389-404.
69. Gage FH, Kempermann G, Palmer TD et al. Multipotent progenitor cells in the adult dentate gyrus. J Neurobiol 1998;36:249-266.
70. Kornack DR, Rakic P. Continuation of neurogenesis in the hippocampus of the adult macaque. Proc Natl Acad Sci U S A 1999;96:5768-5773.
71. Seaberg RM, van der Kooy D. Adult rodent neurogenic regions: The ventricular subependyma contains neural stem cells, but the dentate gyrus contains progenitors. J Neurosci 2002;22:1784-1793.
72. Ueki T, Tanaka M, Yamashita K et al. A novel secretory factor, neurogenesin-1, provides neurogenic environmental cues for neural stem cells in the adult hippocampus. J Neurosci 2003;23:11732-11740.
73. Seri B, Garcia-Verdugo JM, Collado-Morente L et al. Cell types, lineage, and architecture of the germinal zone in the adult dentate gyrus. J Comp Neurol 2004;478:359-378.
74. Fontana X, Nacher J, Soriano E et al. Cell proliferation in the adult hippocampal formation of rodents and its modulation by entorhinal and fimbria-fornix afferents. Cereb Cortex 2006;16:301-312.
75. Hermann A, Maisel M, Liebau S et al. Mesodermal cell types induce neurogenesis from adult human hippocampal progenitor cells. J Neurochem 2006;98:629-640.
76. Seri B, Herrera DG, Gritti A et al. Composition and organization of the SCZ: A large germinal layer containing neural stem cells in the adult mammalian brain. Cereb Cortex 2006;16(suppl 1):i103-i111.
77. Hermann A, Maisel M, Wegner F et la. Multipotent neural stem cells from the adult tegmentum with dopaminergic potential develop essential properties of functional neurons. STEM CELLS 2006;24:949-964.
78. Anthony TE, Klein C, Fishell G et al. Radial glia serve as neuronal progenitors in all regions of the central nervous system. Neuron 2004;41:881-890.
79. Merkle FT, Tramontin AD, Garcia-Verdugo JM et al. Radial glia give rise to adult neural stem cells in the subventricualr zone. Proc Natl Acad Sci U S A 2004;101:17528-17532.
80. Merkle FT, Alvarez-Buylla A. Neural stem cells in mammalian development. Curr Opin Cell Biol 2006;18:704-709.
81. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992;255:1707-1710.
82. Vescovi AL, Reynolds BA, Fraser DD et al. bFGF regulates the proliferative fate of unipotent (neuronal) and bipotent (neuronal/astroglial) EGF-generated CNS progenitor cells. Neuron 1993;11:951-966.
83. Gage FH, Coates OW, Palmer RD et al. Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci U S A 1995;92:11879-11883.
84. Bartlett PF. Pluripotential hemopoietic stem cells in adult mouse brain. Proc Natl Acad Sci U S A 1982;79:2722-2725.
85. Bjornson CRR, Rietze RL, Reynolds BA et al. Turning brain into blood: A hematopoietic fate adopted by adult neural stem cells in vivo. Science 1999;283:534-537.
86. Shih CC, Weng Y, Mamelak A et al. Identification of a candidate human neurohematopoietic stem-cell population. Blood 2001;98:2412-2422.
87. Galli R, Borello U, Gritti A et al. Skeletal myogenic potential of human and mouse neural stem cells. Nat Neurosci 2000;3:986-991.
88. Rietze RL, Valcanis H, Brooker GF et al. Purification of a pluripotent neural stem cell from the adult mouse brain. Nature 2001;412:736-739.
89. Clarke DL, Johansson CB, Wilbertz J et al. Generalized potential of neural stem cells. Science 2000;288:1660-1663.
90. Kilpatrick TJ, Bartlett PF. Cloning and growth of multipotential neural precursors-requirements for proliferation and differentiation. Neuron 1993;10:255-265.
91. Davis AA, Temple S. A self-renewing multipotential stem cell in embryonic rat cerebral cortex. Nature 1994;372:263-266.
92. Chalmers-Redman RM, Priestly T, Kemp JA et al. In vitro propagation and inducible differentiation of multipotent progenitor cells from human fetal brain. Neuroscience 1997;76:1121-1128.
93. Carpenter MK, Cui X, Hu ZY et al. In vitro expansion of a multipotent population of human neural progenitor cells. Exp Neurol 1999;158:265-278.
94. Uchida N, Buck DW, He D et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 2000;97:14720-14725.
95. Bronner-Fraser M, Fraser S. Cell lineage analysis reveals multipotency of some avian neural crest cells. Nature 1988;335:161-164.
96. Baroffio A, Dupin E, Le Duarin N. Common precursors for neural and mesenchymal derivatives in the cephalic neural crest. Development 1991;112:301-305.
97. Stemple DL, Anderson DJ. Isolation of a stem cell for neurons and glia from the mammalian neural crest. Cell 1992;71:973-985.
98. Morrison SJ, White PM, Zock C et al. Prospective identification of, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Cell 1999;96:737-749.
99. Crane JF, Trainor PA. Neural crest stem and progenitor cells. Annu Rev Cell Dev Biol 2006;22:267-286.
100. Itoh M, Kim CH, Palardy G et al. Mind bomb is a ubiquitin ligase that is essential for efficient activation of Notch signaling by delta. Dev Cell 2003;4:67-82.
101. Louvi A, Artavanis-Tsakonas S. Notch signaling in vertebrate neural development. Nat Rev Neurosci 2006;7:93-102.
102. Barsi JC, Rajendra R, Wu JI et al. Mind bomb1 is a ubiquitin ligase essential for mouse embryonic development and Notch signaling. Mech Dev 2005;122:1106-1117.
103. Koo BK, Lim HS, Song R et al. Mind bomb 1 is essential for generating functional Notch ligands to activate Notch. Development 2005;132:3459-3470.
104. Tasaki T, Mulder LC, Iwamatsu A et al. A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize Ndegrons. Mol Cell Biol 2005;25:7120-7136.
105. Meinnel T, Serero A, Giglione C. Impact of the N-terminal amino acid on targeted protein degradation. Biol Chem 2006;387:839-851.
106. An JY, Seo JW, Tasaki T et al. Impaired neurogenesis and cardiovascular development in mice lacking the E3 ubiquitin ligases UBR1 and UBR2 of the N-end rule pathway. Proc Natl Acad Sci U S A 2006;103:6212-6217.
107. Groisman R, Polanowska J, Kuraoka I et al. The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 2003;113:357-367.
108. Angers S, Li T, Yi X et al. Molecular architecture and assembly of the DDB1-CUL4A ubiquitin ligase machinery. Nature 2006;443:590-593.
109. Bondar T, Kalinina A, Khair L et al. Cul4A and DDB1 associate with Skp2 to target p27Kip1 for proteolysis involving the COP9 signalosome. Mol Cell Biol 2006;26:2531-2539.
110. Cang Y, Zhang J, Nicholas SA et al. Deletion of DDB1 in mouse brain and lens lead to p53-dependent elimination of proliferating cells. Cell 2006;127:929-940.
111. Sakurai M, Ayukawa K, Setsuie R et al. Ubiquitin C-terminal hydrolase L1 regulates the morphology of neural progenitor cells and modulates their differentiation. J Cell Sci 2006;119:162-171.
112. Liu Y, Fallon L, Lashuel HA et al. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 2002;111:209-218.
113. Osaka H, Wang YL, Takada S et al. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet 2003;12:1945-1958.
114. Qiu L, Joazeiro C, Fang N et al. Recognition and ubiquitination of Notch by Itch, a Hect-type E3 ubiquitin ligase. J Biol Chem 2000;275:35734-35737.
115. Oberg C, Li J, Pauley A et al. The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J Biol Chem 2001;276:35847-35853.
116. Wu G, Lyapina S, Das I et al. SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation. Mol Cell Biol 2001;21:7403-7415.
117. McGill MA, McGlade CJ. Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J Biol Chem 2003;278:23196-23203.
118. Lai EC, Deblandre GA, Kintner C et al. Drosophila neuralized is a ubiquitin ligase that promotes the internalization and degradation of delta. Dev Cell 2001;1:783-794.
119. Lai EC, Roegiers F, Qin X et al. The ubiquitin ligase Drosophila Mind bomb promotes Notch signaling by regulating the localization and activity of Serrate and Delta. Development 2005;132:2319-2332.
120. Song R, Koo BK, Yoon KJ et al. Neuralized-2 regulates a Notch ligand in cooperation with Mind bomb-1. J Biol Chem 2006;281:36391-36400.
121. Nie J, McGill MA, Dermer M et al. LNX functions as a RING type E3 ubiquitin ligase that targets the cell fate determinant Numb for ubiquitin-dependent degradation. EMBO J 2002;21:93-102.
122. Kuo CT, Mirzadeh Z, Soriano-Navarro M et al. Postnatal deletion of Numb/Numblike reveals repair and remodeling capacity in the subventricular neurogenic niche. Cell 2006;127:1253-1264.
123. Arnaud L, Ballif BA, Cooper JA. Regulation of protein tyrosine kinase signalling by substrate degradation during brain development. Mol Cell Biol 2003;23:9293-9302.
124. Bock HH, Jossin Y, May P et al. Apolipoprotein E receptors are required for reelin-induced proteasomal degradation of the neuronal adaptor protein Disabled-1. J Biol Chem 2004;279:33471-33479.
125. Patrick GN, Zhou P, Kwon YT et al. p35, the neuronal-specific activator of cyclin-dependent kinase 5 (Cdk5) is degraded by the ubiquitin-proteasome pathway. J Biol Chem 1998;273:24057-24064.
126. Saito T, Onuki R, Fujita Y et al. Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation. J Neurosci 2003;23:1189-1197.
127. Mellodew K, Suhr R, Uwanogho DA et al. Nestin expression is lost in a neural stem cell line through a mechanism involving the proteasome and Notch signalling. Brain Res Dev Brain Res 2004;151:13-23.
128. Mikkola HKA, Orkin SH. The journey of developing hematopoietic cells. Development 2006;133:3733-3744.
129. Cumano A, Godin I. Ontogeny of the hematopoietic system. Annu Rev Immunol 2007;25:745-785.
130. Moore MA, Metcalf D. Ontogeny of the haematopoietic system: Yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo. Br J Haematol 1970;18:279-296.
131. Liu CP, Auerbach R. In vitro development of murine T cells from prethymic and preliver embryonic yolk sac hematopoietic stem cells. Development 1991;113:1315-1323.
132. Yoder MC, Hiatt K, Dutt P et al. Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. Immunity 1997;7:335-344.
133. Medvinsky AL, Samoylina NL, Muller AM et al. An early pre-liver intraembryonic source of CFU-S in the developing mouse. Nature 1993;364:64-67.
134. Müller AM, Medvinsky A, Strouboulis J et al. Development of hematopoietic stem cell activity in the mouse embryo. Immunity 1994;1:291-301.
135. Medvinsky A, Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 1996;86:897-906.
136. Tavian M, Coulombel L, Luton D et al. Aorta-associated CD34+ hematopoietic cells in the early human embryo. Blood 1996;87:67-72.
137. Alvarez-Silva M, Belo-Diabangouaya P, Salaun J et al. Mouse placenta is a major hematopoietic organ. Development 2003;130:5437-5444.
138. Gekas C, Dierterlen-Lievre F, Orkin SH et al. The placenta is a niche for hematopoietic stem cells. Dev Cell 2005;8:365-375.
139. Ottersbach K, Dzierzak E. The murine placenta contains hematopoietic stem cells within the vascular labyrinth region. Dev Cell 2005;8:377-387.
140. Sanchez MJ, Holmes A, Miles C et al. Characterization of the first definitive hematopoietic stem cells in the AGM and liver of the mouse embryo. Immunity 1996;5:513-525.
141. Palis J, Chan RJ, Koniski A et al. Spatial and temporal emergence of high proliferative potential hematopoietic precursors during murine embryogenesis. Proc Natl Acad Sci U S A 2001;98:4528-4533.
142. Godin I, Garcia-Porrero JA, Dieterlen-Lievre F et al. Stem cell emergence and hemopoietic activity are incompatible in mouse intraembryonic sites. J Exp Med 1999;190:43-52.
143. Wolber FM, Leonard E, Michael S et al. Roles of spleen and liver in development of the murine hematopoietic system. Exp Hematol 2002;30:1010-1019.
144. Delassus S, Cumano A. Circulation of hematopoietic progenitors in the mouse embryo. Immunity 1996;4:97-106.
145. Zhang J, Niu C, Ye L et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003;425:836-841.
146. Kiel MJ, Yilmaz OH, Iwashita T et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005;121:1109-1121.
147. Sugiyama T, Kohara H, Noda M et al. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006;25:977-988.
148. Attar EC, Scadden DT. Regulation of hematopoietic stem cell growth. Leukemia 2004;18:1760-1768.
149. Wilson A, Trumpp A. Bone-marrow haematopoietic stem-cell niches. Nat Rev Immunol 2006;6:93-106.
150. Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic stem cell transplantation. Annu Rev Immunol 2007;25:139-170.
151. Becker A, McCulloch E, Till J. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 1963;197:452-454.
152. Lewis JP, Trobaugh FE Jr. Haematopoietic stem cells. Nature 1964; 204:589-590.
153. Müller-Sieburg CE, Whitlock CA, Weissman IL. Isolation of two early B lymphocyte progenitors from mouse marrow: A committed pre-pre-B cell and a clonogenic Thy-1lo hematopoietic stem cell. Cell 1986;44:653-662.
154. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science 1988;241:58-62.
155. Osawa M, Hanada K, Hamada H et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996;273:242-245.
156. Kondo M, Weissman IL, Akashi K. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 1997;91:661-672.
157. Parakh KA, Kannan K. Demonstration of a ubiquitin binding site on murine haemopoietic progenitor cells: Implication of ubiquitin in homing and adhesion. Br J Haematol 1993;84:212-218.
158. Daino H, Shibayama H, Machii et al. Extracellular ubiquitin regulates the growth of human hematopoietic cells. Biochem Biophys Res Commun 1996;223:226-228.
159. Hardy CL, Kishimoto T, Harjes K et al. Homing of a cloned multipotential stem cell line in spleen and intraperitoneal membrane. Exp Hematol 1986;14:636-642.
160. Henschler R, Fehervizyova Z, Bistrian R et al. A mouse model to study organ homing behaviour of haemopoietic progenitor cells reveals high selectivity but low efficiency of multipotent progenitors to home into haemopoietic organs. Br J Haematol 2004;126:111-119.
161. Naujokat C, Sezer O, Zinke H et al. Proteasome inhibitors induce caspase-dependent apoptosis and accumulation of p21WAF1/Cip1 in human immature leukemic cells. Eur J Haematol 2000;65:221-236.
162. Zavrski I, Naujokat C, Niemöller K et al. Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion. J Cancer Res Clin Oncol 2003;129:383-391.
163. Guzman ML, Neering SJ, Upchurch D et al. Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukaemia cells. Blood 2001;98:2301-2307.
164. Guzman ML, Swiderski CF, Howard DS et al. Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci U S A 2002;99:16220-16225.
165. Palombella VJ, Rando OJ, Goldberg AL et al. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 1994;78:773-785.
166. Mayo MW, Wang CY, Cogswell PC et al. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 1997;278:1812-1815.
167. Basseres DS, Baldwin AS. Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression. Oncogene 2006;25:6817-6813.
168. Pyatt DW, Stillman WS, Yang Y et al. An essential role for NF-κB in human CD34+ bone marrow cell survival. Blood 1999;93:3302-3308.
169. Nakata S, Matsumura I, Tanaka H et al. NF-κB family proteins participate in multiple steps of hematopoiesis through elimination of reactive oxygen species. J Biol Chem 2004;279:55578-55586.
170. Traenckner EB, Wilk S, Baeuerle PA. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκBα that is still bound to NF-κB. EMBO J 1994;13:5433-5441.
171. Chen E, Hrdlickova R, Nehyba J et al. Degradation of proto-oncoprotein c-Rel by the ubiquitin-proteasome pathway. J Biol Chem 1998;273:35201-35207.
172. Saccani S, Marazzi I, Beg AA et al. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor κB response. J Exp Med 2004;200:107-113.
173. Hayden MS, Ghosh S. Signaling to NF-κB. Genes Dev 2004;18:2195-2224.
174. Grossmann M, Metcalf D, Merryful J et al. The combined absence of the transcription factors Rel and RelA leads to multiple hemaopoietic cell defects. Proc Natl Acad Sci U S A 1999;96:11848-11853.
175. Hernandez-Hernandez A, Ray P, Litos G et al. Acetylation and MAPK phosphorylation cooperates to regulate the degradation of active GATA-1. EMBO J 2006;25:3264-3274.
176. Minegishi N, Suzuki N, Kawatani Y et al. Rapid turnover of GATA-2 via ubiquitin-proteasome protein degradation. Genes Cells 2005;10:693-704.
177. Koga S, Yamaguchi N, Abe T et al. Cell cycle-dependent oscillation of GATA-2 expression in hematopoietic cells. Blood 2007;109:4200-4208.
178. Pevny L, Simon MC, Robertson E et al. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 1991;349:257-260.
179. Takahashi S, Komeno T, Suwabe N et al. Role of GATA-1 in proliferation and differentiation of definitive erythroid and megakaryocytic cells in vivo. Blood 1998;92:434-442.
180. Zheng J, Kitajima K, Sakai E et al. Differential effects of GATA-1 on proliferation and differentiation of erythroid lineage cells. Blood 2006;107:520-527.
181. Labbaye C, Valtieri M, Barberi T et al. Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis. J Clin Invest 1995;95:2346-2358.
182. Tsai FY, Orkin SH. Trasncription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 1997;89:3636-3643.
183. Ling KW, Ottersbach K, van Hamburg JP et al. GATA-2 plays two functional roles during ontogeny of hematopoietic stem cells. J Exp Med 2004;200:871-882.
184. Minegishi N, Suzuki N, Yokomizo T et al. Expression and domainspecific function of GATA-2 during differentiation of the hematopoietic precursor cells in midgestation embryos. Blood 2003;102:896-905.
185. Robert-Moreno A, Espinosa L, de la Pompa JL et al. RBPjκ-dependent Notch function regulates Gata2 and is essential for the formation of intra-embryonic hematopoietic cells. Development 2005;132:1117-1126.
186. de Pooter RF, Schmitt TM, de la Pompa JL et al. Notch signaling requires GATA-2 to inhibit myelopoiesis from embryonic stem cells and primary hemopoietic progenitors. J Immunol 2006;176:5267-5267.
187. Ohishi K, Katayama N, Shiku H et al. Notch signalling in hematopoiesis. Semin Cell Dev Biol 2003;14:143-150.
188. Suzuki T, Chiba S. Notch signalling in hematopoietic stem cells. Int J Hematol 2005;82:285-294.
189. Alhadlaq A, Mao JJ. Mesenchymal stem cells: Isolation and therapeutics. Stem Cells Dev 2004;13:436-448.
190. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006;119:2204-2213.
191. Guillot PV, O'Donoghue K, Kurata H et al. Fetal stem cells: Betwixt and between. Semin Reprod Med 2006;24:340-347.
192. Guillot PV, Gotherstrom C, Chan J et al. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. STEM CELLS 2007;25:646-654.
193. Holmes C, Stanford WL. Concise review: Stem cell antigen-1: Expression, function, and enigma. STEM CELLS 2007;25:1339-1347.
194. Dennis JE, Carbillet JP, Caplan AI et al. The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs 2002;170:73-82.
195. Both SK, Muijsenberg AJ, Blitterswijk CA et al. A rapid and efficient method for expansion of human mesenchymal stem cells. Tissue Eng 2007;13:3-9.
196. Oswald J, Boxberger S, Jorgensen B et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. STEM CELLS 2004;22:377-384.
197. Gang EJ, Bosnakovski D, Figueiredo CA et al. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 2007;109:1743-1751.
198. Pansky A, Roitzheim B, Tobiasch E. Differentiation potential of adult human mesenchymal stem cells. Clin Lab 2007;53:81-84.
199. Yamada Y, Sakurada K, Takeda Y et al. Single-cell-derived mesenchymal stem cells overexpressing Csx/Nkx2.5 and GATA4 undergo the stochastic cardiomyogenic fate and behave like transient amplifying cells. Exp Cell Res 2007;313:698-706.
200. Deng J, Petersen BE, Steindler DA et al. Mesenchymal stem cells spontaneously express neural proteins in culture and are neurogenic after transplantation. STEM CELLS 2006;24:1054-1064.
201. Tropel P, Platet N, Platel JC et al. Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells. STEM CELLS 2006;24:2868-2876.
202. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 1999;96:10711-10716.
203. Talens-Visconti R, Bonora A, Jover R et al. Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. World J Gastroenterol 2006;12:5834-5845.
204. Chun-mao H, Su-Yi W, Ping-Ping L et al. Human bone marrow-derived mesenchymal stem cells differentiate into epidermal-like cells in vitro. Differentiation 2007;75:292-298.
205. Timper K, Seboek D, Eberhardt M et al. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun 2006;341:1135-1140.
206. Jeon SJ, Oshima K, Heller S et al. Bone marrow mesenchymal stem cells are progenitors in vitro for inner ear hair cells. Mol Cell Neurosci 2007;34:59-68.
207. Satija NK, Gurudutta GU, Sharma S et al. Mesenchymal stem cells: Molecular targets for tissue engineering. Stem Cells Dev 2007;16:7-23.
208. Wu S, De Luca F. Inhibition of the proteasomal function in chondrocytes down-regulates growth plate chondrogenesis and longitudinal bone growth. Endocrinology 2006;147:3761-3768.
209. Hwang SG, Yu SS, Ryu JH et al. Regulation of beta-catenin signaling and maintenance of chondrocyte differentiation by ubiquitin-independent proteasomal degradation of alpha-catenin. J Biol Chem 2005;280:12758-12765.
210. Ryu JH, Kim SJ, Kim SH et al. Regulation of the chondrocyte phenotype by beta-catenin. Development 2002;129:5541-5550.
211. Genini D, Catapano CV. Control of peroxisome proliferator-activated receptor fate by the ubiquitin-proteasome system. J Recept Signal Transduct Res 2006;26:679-692.
212. Cheng H, Jiang W, Phillips FM et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003;85-A:1544-1552.
213. Friedman MS, Long MW, Hankenson KD. Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem 2006;98:538-554.
214. Garrett IR, Chen D, Gutierrez G et al. Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. J Clin Invest 2003;111:1771-1782.
215. Gruendler C, Lin Y, Farley J et al. Proteasomal degradation of Smad1 induced by bone morphogenetic proteins. J Biol Chem 2001;276:46533-46543.
216. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004;22:233-241.
217. Shen R, Chen M, Wang YJ et al. Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation. J Biol Chem 2006;281:3569-3576.
218. Sangadala S, Boden SD, Viggeswarapu M et al. LIM mineralization protein-1 potentiates bone morphogenetic protein responsiveness via a novel interaction with Smurf1 resulting in decreased ubiquitination of Smads. J Biol Chem 2006;281:17212-17219.